Docetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate Cancer
Status:
Recruiting
Trial end date:
2030-01-01
Target enrollment:
Participant gender:
Summary
This randomized phase II trial studies how well docetaxel works when given with or without
ascorbic acid in treating patients with prostate cancer that has spread to other places in
the body. Drugs used in chemotherapy, such as docetaxel, work in different ways to stop the
growth of tumor cells, either by killing the cells, by stopping them from dividing, or by
stopping them from spreading. Ascorbic acid (vitamin C) is a water-soluble vitamin that may
help inhibit the growth of cancer cells. It is not yet known whether docetaxel works better
when given with or without ascorbic acid in treating prostate cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins